Classification of non-Hodgkin's lymphoma on the basis of morphology alone may not provide adequate information about the biological behaviour. A more complete picture can be obtained by supplementing morphology with immunological, cytokinetic, cytogenetic, and other biological markers. Differences in DNA ploidy have recently been reported within various tumours, including non-Hodgkin's lymphoma, and these differences may have prognostic implications.1 '4 In non-Hodgkin's lymphoma differences in the S fraction of the cell cycle and RNA content have also been reported and these seem to influence survival. [5] [6] [7] [8] [9] This study was carried out to ascertain the incidence of DNA aneuploidy, determined by flow cytometry, and to correlate aneuploidy and the percentage of S phase cells within the various histological types of non-Hodgkin's lymphoma.
Accepted for publication 9 April 1986 Material and methods Fresh lymph node (n = 116), spleen (n = 14), or affected extranodal lymphoid tissue (n = 16) specimens were obtained by surgical excision. Affected peripheral blood and bone marrow were studied in nine and five cases, respectively. In all cases routine histological sections and cytological preparations were available for morphological diagnosis. NonHodgkin's lymphomas were classified according to the International Working Formulation.'0 Cell suspensions were prepared by gently pressing the minced lymph node through a stainless steel mesh into phosphate buffered saline at pH 7-2. Mononuclear cell suspensions were prepared from blood and marrow on a ficoll and hypaque gradient. Viability was determined by use of trypan blue and was 80% or greater in all cases.
Tritiated thymidine labelling was performed on an aliquot of the sample containing 2 x 106 cells in 5 ml aneuploidy, shown by the presence of more than one GI/GO peak. -ga2hr 3. group.bmj.com on June 19, 2017 -Published by http://jcp.bmj.com/ Downloaded from DNA ploidy and kinetics of lymphoma classified as diffuse small cleaved cell lymphoma on histological examination. In another patient biopsy specimens from two different sites showed the presence of an aneuploid population in one. The table shows the distribution of DNA aneuploidy in relation to various histological subtypes. The low, intermediate, and high grade lymphomas had 14% (six of 43), 47% (27 of 58), and 63% (five of eight) cases, respectively, which showed DNA aneuploidy. These differences in the incidence of aneuploidy were significant (X2 = 14 5; p = 0-0007). The incidence of aneuploidy increased significantly the higher the grade (X2 test for trend = A varying incidence of aneuploidy has been reported in non-Hodgkin's lymphoma-from 29 to 80%.1 3 6 7 9 In our study the incidence was similar to that reported in a recent series comprising a large number of cases and in which the same criterion was used for the definition of aneuploidy.7 In our study the incidence of aneuploidy increased from low to high grade lymphomas. In another recent study, in which the lymphomas were subclassified according to the International Working Formulation, the incidence of aneuploidy in various histological subtypes was similar to that found in our study.' The variable incidence reported could be due, in part, to the different criteria used in the diagnosis of DNA aneuploidy and to the inclusion of different proportions of various histological grades of non-Hodgkin's lymphoma.
A wide range of labelling index values was observed among different histological subtypes of non-Hodgkin's lymphoma and even within a given histological subtype. This reflects the heterogeneity of non-Hodgkin's lymphoma with regard to the growth fraction, even within the one histological subtype. The technique of (3H) labelling, however, is laborious and is being replaced by S fraction estimations using flow cytometry, a quick and accurate method of quantifying the number of cells in DNA synthetic phase. On the basis of ours and other published studies, there seems to be a good correlation between the percentage of S phase cells and the histological subtypes of malignant lymphoma. The low grade lymphomas had a lower percentage of cells in S phase than the intermediate and high grade lymphomas. It has been recently reported that patients with nonHodgkin's lymphoma with less than 5% S fraction have a significantly better survival than those with greater than 5% S fraction cells.8 The percentage of cells in the S phase of low grade lymphomas was not found to be significantly different from that of reactive lymphoid hyperplasia.
The calculation of S fraction is often difficult in patients who have a mixture of neoplastic and nonneoplastic tissues. In such cases isolation of neoplastic populations by labelling with monoclonal antibodies
